Skip to main content
Premium Trial:

Request an Annual Quote

SoftGenetics, Elsevier Sign Software Integration Deal

SoftGenetics has signed a strategic agreement with Elsevier to integrate Elsevier's Pathway Studio with its NextGene software.

The combined solution will provide customers with an integrated workflow for analyzing next-generation sequence data that covers genome alignment through to differential gene expression analysis and biological pathway analysis based on curated information from scientific literature.

"Our goal is to ensure that our customers quickly and easily find evidence and data that is relevant and authoritative … [and] our collaboration with SoftGenetics meets this goal," Jaqui Hodgkinson, Elsevier's vice president of product development for biology products, said in a statement. "This integration will reduce their workload, reduce complexity, and increase the accuracy of their analysis."

"Our collaboration extends the functionality of both SoftGenetics' NextGene software and Elsevier's products," Kevin LeVan, SoftGenetics' product manager for NextGene, added. "With NextGene and Pathway Studio's software integration, our customers now have a streamlined process to go from high-throughput sequencing to identifying relevant pathways."

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.